Maxime Jullien
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Hematology 21
- Hematopoietic Stem Cell Transplantation 16
- Acute Myeloid Leukemia Research 5
-
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 5
- Co-authors
- Alice Garnier (30 shared papers)Amandine Le Bourgeois (29 shared papers)Pierre Péterlin (30 shared papers)Thierry A. Guillaume (27 shared papers)Patrice Chevallier (32 shared papers)Cyrille Touzeau (11 shared papers)Marie C. Béné (21 shared papers)Philippe Moreau (9 shared papers)
- Journals
- Blood (4 papers)British Journal of Haematology (3 papers)Cancers (3 papers)Cells (2 papers)Annals of Hematology (2 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Maxime Jullien
39 papers receiving 289 citations
Peers
Comparison fields: 5 of 47
- Hematology 108
- Infectious Diseases 119
- Immunology 74
- Oncology 84
- Genetics 15
Countries citing papers authored by Maxime Jullien
This map shows the geographic impact of Maxime Jullien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Jullien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Jullien more than expected).
Fields of papers citing papers by Maxime Jullien
This network shows the impact of papers produced by Maxime Jullien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Jullien. The network helps show where Maxime Jullien may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Jullien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 29 | |
| 2 | 2019 | 28 | |
| 3 | 2021 | 25 | |
| 4 | 2022 | 24 | |
| 5 | 2021 | 21 | |
| 6 | 2020 | 17 | |
| 7 | 2021 | 15 | |
| 8 | 2019 | 12 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2020 | 8 | |
| 15 | 2024 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2024 | 4 | |
| 20 | 2024 | 4 |
About Maxime Jullien
Maxime Jullien is a scholar working on Hematology, Infectious Diseases, Immunology, Oncology and Animal Science and Zoology, having authored 45 papers that have together received 291 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers), COVID-19 Clinical Research Studies (5 papers), Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (108 citations), Infectious Diseases (119 citations), Immunology (74 citations), Oncology (84 citations) and Genetics (15 citations). Maxime Jullien has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Alice Garnier, Amandine Le Bourgeois, Pierre Péterlin, Thierry A. Guillaume, Patrice Chevallier, Cyrille Touzeau, Marie C. Béné, Philippe Moreau, Marianne Coste‐Burel and Thomas Gastinne. Their work appears in journals such as Blood, British Journal of Haematology, Cancers, Cells and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.